Journal: Clinical and Translational Medicine
Article Title: DNTTIP1 drives leukaemogenesis through MiDAC‐mediated epigenetic silencing of BMF
doi: 10.1002/ctm2.70603
Figure Lengend Snippet: Deoxynucleotidyl transferase terminal‐interacting protein 1 (DNTTIP1) interacts with SP1 to repress the transcription of BCL2‐modifying factor (BMF). (A) Motif analysis identifies the top 15 transcription factors enriched within DNTTIP1‐bound genomic regions. (B) Venn diagram showing the overlap of multi‐omics binding motifs (assay for transposase‐accessible chromatin using sequencing [ATAC‐seq] and cleavage under targets and tagmentation [CUT&Tag]) and predicated JASPAR motifs anchored to the DNTTIP1‐bound BMF promoter in RS4;11 cells (left). Table presenting the SP1 motif logo and position‐weight matrix (right). (C‒E) Reciprocal co‐immunoprecipitation (Co‐IP) analysis in RS4;11 cells demonstrated binding of endogenous SP1 to DNTTIP1 and HDAC1/2 ( n = 3). (F) Correlation analysis of SP1 with DNTTIP1 and HDAC1/2 in The Cancer Genome Atlas (TCGA)‐LAML. Pearson correlation coefficients were computed using GEPIA 2 ( http://gepia2.cancer‐pku.cn/#index ). (G) Immunoblot (left) and RT‐qPCR (middle) analyses demonstrating SP1 knockout using two different single‐guide RNAs (sgSP1_1 and sgSP1_2). (H) Cell counting of RS4;11 cells expressing sgSP1_1 and sgSP1_2 compared with control (lacZ) (right) ( n = 3). (I) Flow cytometric analysis of Annexin V/propidium iodide (PI) staining in RS4;11 cells with SP1 knockout (sgSP1_1 and sgSP1_2) versus control (lacZ) ( n = 3). (J‒L) RT‐qPCR analysis of mRNA expression of BH3‐only genes (BMF, PUMA and NOXA) in leukaemia cells following DNTTIP1 knockdown (J), MS‐275 treatment (K) or FK228/Merck60 treatment (L). Data represent mean ± standard deviation (SD) of three independent experiment. * p < .05, ** p < .01, *** p < .001, **** p < .0001. (M) Schematic of chromatin immunoprecipitation quantitative PCR (ChIP‐qPCR) locus‐specific BMF primer locations (left). ChIP‐qPCR analysis showing the HA (DNTTIP1) enrichment on BMF promoter in HA‐tagged DNTTIP1 overexpressed RS4;11 cells (right). (N) ChIP‐qPCR analysis showing the HDAC1 enrichment at BMF promoter in control (pLKO) and DNTTIP1 knockdown (shDNT_4) RS4;11 cells. (O) ChIP‐qPCR analysis showing the HDAC2 (left) and H3K27ac (right) enrichment at BMF promoter in control (pLKO) and DNTTIP1 knockdown (shDNT_4) RS4;11 cells. (P) ChIP‐qPCR analysis showing the SP1 enrichment at BMF promoter in control (pLKO) and DNTTIP1 knockdown (shDNT_4) RS4;11 cells. (Q) ChIP‐qPCR analysis showing the HDAC1 (left) and H3K27ac (right) enrichment at BMF promoter in control (lacZ) and SP1 knockout (sgSP1_2) RS4;11 cells.
Article Snippet: Briefly, 5 μg GST‐tagged HDAC1 (SignalChem, H83‐30G) and 5 μg His‐tagged DNTTIP1 (Solarbio, P05485 ) were mixed with 20 μL pre‐washed beads (GST‐labelled magnetic beads for GST pull‐down; NTA‐Ni beads for His pull‐down) in pull‐down buffer.
Techniques: Biomarker Discovery, Binding Assay, Sequencing, Immunoprecipitation, Co-Immunoprecipitation Assay, Western Blot, Quantitative RT-PCR, Knock-Out, Cell Counting, Expressing, Control, Staining, Knockdown, Standard Deviation, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction, ChIP-qPCR